bioAffinity Technologies, Inc. - Common Stock (BIAF)

About bioAffinity Technologies, Inc. - Common Stock (BIAF)

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

bioAffinity Technologies, Inc. - Common Stock News